Safety, Tolerability, Pharmacokinetics, and Food Effect Study of RV299 in Healthy Adults

NCT06033612 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

DRUG: RV299
DRUG: Placebo
DRUG: Midazolam

Sponsor

Pfizer